A detailed history of Tower Research Capital LLC (Trc) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,989 shares of PACB stock, worth $22,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,989
Previous 44,663 73.16%
Holding current value
$22,179
Previous $61,000 67.21%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $2.17 $39,208 - $70,902
-32,674 Reduced 73.16%
11,989 $20,000
Q2 2024

Aug 13, 2024

BUY
$1.36 - $3.65 $55,369 - $148,602
40,713 Added 1030.71%
44,663 $61,000
Q1 2024

May 15, 2024

SELL
$3.52 - $9.59 $219,105 - $596,939
-62,246 Reduced 94.03%
3,950 $14,000
Q4 2023

Feb 13, 2024

BUY
$5.97 - $10.36 $345,770 - $600,030
57,918 Added 699.66%
66,196 $649,000
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $26,253 - $44,436
-3,190 Reduced 27.82%
8,278 $69,000
Q2 2023

Aug 14, 2023

SELL
$9.97 - $14.05 $258,332 - $364,049
-25,911 Reduced 69.32%
11,468 $152,000
Q1 2023

May 09, 2023

BUY
$7.94 - $12.02 $281,893 - $426,746
35,503 Added 1892.48%
37,379 $433,000
Q4 2022

Feb 10, 2023

SELL
$5.67 - $11.2 $422,840 - $835,240
-74,575 Reduced 97.55%
1,876 $16,000
Q3 2022

Nov 10, 2022

BUY
$3.93 - $8.57 $252,675 - $550,999
64,294 Added 528.86%
76,451 $444,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $11,171 - $28,984
-2,779 Reduced 18.61%
12,157 $54,000
Q1 2022

May 12, 2022

BUY
$8.43 - $20.9 $47,536 - $117,855
5,639 Added 60.65%
14,936 $136,000
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $112,979 - $176,449
-5,866 Reduced 38.69%
9,297 $190,000
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $108,215 - $152,442
4,353 Added 40.27%
15,163 $387,000
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $1.19 Million - $1.92 Million
-53,359 Reduced 83.15%
10,810 $378,000
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $1.17 Million - $2.28 Million
44,508 Added 226.38%
64,169 $2.14 Million
Q4 2020

Feb 16, 2021

SELL
$10.5 - $28.5 $1.37 Million - $3.71 Million
-130,267 Reduced 86.89%
19,661 $510,000
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $430,330 - $1.18 Million
119,205 Added 388.0%
149,928 $1.48 Million
Q2 2020

Aug 13, 2020

BUY
$2.65 - $4.03 $59,185 - $90,006
22,334 Added 266.23%
30,723 $106,000
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $3,143 - $7,006
1,332 Added 18.87%
8,389 $26,000
Q4 2019

Feb 07, 2020

BUY
$4.6 - $5.57 $29,301 - $35,480
6,370 Added 927.22%
7,057 $36,000
Q3 2019

Nov 05, 2019

BUY
$4.99 - $6.16 $3,428 - $4,231
687 New
687 $4,000
Q2 2019

Aug 13, 2019

SELL
$5.92 - $7.41 $12,947 - $16,205
-2,187 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$6.8 - $7.4 $14,871 - $16,183
2,187 New
2,187 $16,000
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $79,389 - $155,594
-19,897 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$3.52 - $5.55 $70,037 - $110,428
19,897 New
19,897 $107,000
Q2 2018

Aug 15, 2018

SELL
$2.11 - $3.92 $43,974 - $81,696
-20,841 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.05 - $3.23 $42,724 - $67,316
20,841 New
20,841 $43,000
Q4 2017

Feb 09, 2018

SELL
$2.59 - $5.44 $30,233 - $63,501
-11,673 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $37,353 - $65,018
11,673
11,673 $61,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $416M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.